Announcements
Eurosurveillance remains in the updated list of the Directory of Open Access Journals (DOAJ). It was first added to the DOAJ on 9 September 2004. Eurosurveillance is also listed in the Securing a Hybrid Environment for Research Preservation and Access / Rights MEtadata for Open archiving (SHERPA/RoMEO) [2], a database which uses a colour‐coding scheme to classify publishers according to their self‐archiving policy and to show the copyright and open access self-archiving policies of academic journals. Eurosurveillance is listed there as a ‘green’ journal, which means that authors can archive pre-print (i.e. pre-refereeing), post-print (i.e. final draft post-refereeing) and archive the publisher's version/PDF.

ESCAIDE participants are invited to the fifth Eurosurveillance scientific seminar on 30 November 2016

Follow Eurosurveillance on Twitter: @Eurosurveillanc

Read our articles on Zika virus infection

Read our articles on mcr-1-mediated colistin resistance

Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015. Available from: http://www.eurosurveillance.org / ViewArticle.aspx?ArticleId=21169


Skip Navigation LinksEurosurveillance Archives
Eurosurveillance:
2016        2015        2014        2013        2012        2011        2010        2009        2008        2007        2006       
2005        2004        2003        2002        2001        2000        1999        1998        1997        1996        1995       

Eurosurveillance Editions 2012,  Volume 17:
Dec: 13 | 06 |
Nov: 29 | 22 | 15 | 08 | 01 |
Oct: 25 | 18 | 11 | 04 |
Sep: 27 | 20 | 13 | 06 |
Aug: 30 | 23 | 16 | 09 | 02 |
Jul: 26 | 19 | 12 | 05 |
Jun: 28 | 21 | 14 | 07 |
May: 31 | 24 | 17 | 10 | 03 |
Apr: 26 | 19 | 12 | 05 |
Mar: 29 | 22 | 15 | 08 | 01 |
Feb: 23 | 16 | 09 | 02 |
Jan: 26 | 19 | 12 | 05 |

Eurosurveillance Special Editions 2012,  Volume 17:
  Zoonotic diseases September 2012 - November 2012
  Immunisation registers in Europe and elsewhere - August 2012
  Mycoplasma pneumoniae and Legionella pneumophila - May 2012
  Q fever - January 2012


In this issue:
papers covering the public health response and laboratory aspects concerning a new coronavirus


Eurosurveillance, Volume 17, Issue 39, 27 September 2012

Table of Contents

Miscellaneous

Note from the editors: A new virus bringing back memories from the past
Rapid communications

Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction
Novel coronavirus associated with severe respiratory disease: Case definition and public health measures
Perspectives

I-MOVE: a European network to measure the effectiveness of influenza vaccines
Research articles

Survey of delivery of prophylactic immunoglobulins following exposure to a measles case

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN 1560-7917] - ©2007-2016. All rights reserved.
 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.